drugset / Trial / NCT00026039

Women's Estrogen for Stroke Trial (WEST)

NCT00026039

RandomizedDouble-blind

Summary

To determine if estrogen hormone replacement therapy reduces the risk of stroke or death in postmenopausal women who have already had stroke or a transient ischemic attack (TIA).

Timeline

Start
1993-12
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Estradiol Other / unclassified 1 mg Oral

Indications